ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

KDNY Chinook Therapeutics Inc

40.39
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Chinook Therapeutics Inc KDNY NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 40.39 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
40.39
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/11/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
21/8/202312:21EDGAR2Form 15-12G - Securities registration termination [Section..
16/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202316:02EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/8/202315:39EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11/8/202315:35EDGAR2Form POS AM - Post-Effective amendments for registration..
11/8/202315:31EDGAR2Form 8-K - Current report
11/8/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:06EDGAR2Form 8-K - Current report
01/8/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202306:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/7/202307:15EDGAR2Form 8-K - Current report
28/7/202307:00GLOBEChinook Therapeutics Announces First Patient Enrolled in..
26/7/202315:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/7/202315:01EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
17/6/202306:15GLOBEChinook Therapeutics Presents Data from CHK-336 Phase 1..
12/6/202315:00GLOBEChinook Therapeutics to Present Updated Data from Zigakibart..
12/6/202309:40DJNTrending: Novartis Buying Chinook Therapeutics for Up to..
12/6/202307:09DJNFlurry of European Companies Engaged in Acquisitions, Asset..
12/6/202300:53DJNNovartis to Acquire Chinook Therapeutics for Up to $3.5..
12/6/202300:00GLOBEChinook Therapeutics Enters into Agreement to be Acquired by..
16/5/202307:00GLOBEChinook Therapeutics Announces Partnership with Ionis to..